Cargando…

Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

BACKGROUND: Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms. METHODS: All 302 conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninomiya, Toshifumi, Otsubo, Kohei, Hoshino, Teppei, Shimokawa, Mototsugu, Nakazawa, Megumi, Sato, Yoriko, Mikumo, Hironori, Kawakami, Satoru, Mizusaki, Shun, Mori, Yusuke, Arimura, Hidenobu, Tsuchiya-Kawano, Yuko, Inoue, Koji, Uchida, Yujiro, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379599/
https://www.ncbi.nlm.nih.gov/pubmed/34419004
http://dx.doi.org/10.1186/s12879-021-06574-x
_version_ 1783741039904817152
author Ninomiya, Toshifumi
Otsubo, Kohei
Hoshino, Teppei
Shimokawa, Mototsugu
Nakazawa, Megumi
Sato, Yoriko
Mikumo, Hironori
Kawakami, Satoru
Mizusaki, Shun
Mori, Yusuke
Arimura, Hidenobu
Tsuchiya-Kawano, Yuko
Inoue, Koji
Uchida, Yujiro
Nakanishi, Yoichi
author_facet Ninomiya, Toshifumi
Otsubo, Kohei
Hoshino, Teppei
Shimokawa, Mototsugu
Nakazawa, Megumi
Sato, Yoriko
Mikumo, Hironori
Kawakami, Satoru
Mizusaki, Shun
Mori, Yusuke
Arimura, Hidenobu
Tsuchiya-Kawano, Yuko
Inoue, Koji
Uchida, Yujiro
Nakanishi, Yoichi
author_sort Ninomiya, Toshifumi
collection PubMed
description BACKGROUND: Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms. METHODS: All 302 consecutive patients who were admitted to our institutions and diagnosed with COVID-19 between March and December 2020 were retrospectively assessed. Ultimately, 210 adult patients exhibiting no or mild symptoms on admission were included in the analysis. They were categorized into the stable (no oxygen needed) and worsened (oxygen needed) groups, and their characteristics and laboratory data were compared. RESULTS: Among 210 patients, 49 progressed to a severe disease stage, whereas 161 did not. The mean patient age was 52.14 years, and 126 (60.0%) patients were male. The mean body mass index (BMI) was 23.0 kg/m(2), and 71 patients were overweight (BMI ≥ 25 kg/m(2)). Multivariate logistic analysis showed that old age, overweight, diabetes mellitus (DM), and high serum ferritin levels were independent risk factors for disease progression. CONCLUSIONS: Clinicians should closely observe patients with COVID-19, especially those with risk factors such as old age, overweight, DM, and high serum ferritin levels, regardless of whether they have no or mild symptoms.
format Online
Article
Text
id pubmed-8379599
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83795992021-08-23 Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission Ninomiya, Toshifumi Otsubo, Kohei Hoshino, Teppei Shimokawa, Mototsugu Nakazawa, Megumi Sato, Yoriko Mikumo, Hironori Kawakami, Satoru Mizusaki, Shun Mori, Yusuke Arimura, Hidenobu Tsuchiya-Kawano, Yuko Inoue, Koji Uchida, Yujiro Nakanishi, Yoichi BMC Infect Dis Research BACKGROUND: Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID-19 exhibiting no or mild symptoms. METHODS: All 302 consecutive patients who were admitted to our institutions and diagnosed with COVID-19 between March and December 2020 were retrospectively assessed. Ultimately, 210 adult patients exhibiting no or mild symptoms on admission were included in the analysis. They were categorized into the stable (no oxygen needed) and worsened (oxygen needed) groups, and their characteristics and laboratory data were compared. RESULTS: Among 210 patients, 49 progressed to a severe disease stage, whereas 161 did not. The mean patient age was 52.14 years, and 126 (60.0%) patients were male. The mean body mass index (BMI) was 23.0 kg/m(2), and 71 patients were overweight (BMI ≥ 25 kg/m(2)). Multivariate logistic analysis showed that old age, overweight, diabetes mellitus (DM), and high serum ferritin levels were independent risk factors for disease progression. CONCLUSIONS: Clinicians should closely observe patients with COVID-19, especially those with risk factors such as old age, overweight, DM, and high serum ferritin levels, regardless of whether they have no or mild symptoms. BioMed Central 2021-08-21 /pmc/articles/PMC8379599/ /pubmed/34419004 http://dx.doi.org/10.1186/s12879-021-06574-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ninomiya, Toshifumi
Otsubo, Kohei
Hoshino, Teppei
Shimokawa, Mototsugu
Nakazawa, Megumi
Sato, Yoriko
Mikumo, Hironori
Kawakami, Satoru
Mizusaki, Shun
Mori, Yusuke
Arimura, Hidenobu
Tsuchiya-Kawano, Yuko
Inoue, Koji
Uchida, Yujiro
Nakanishi, Yoichi
Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title_full Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title_fullStr Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title_full_unstemmed Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title_short Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission
title_sort risk factors for disease progression in japanese patients with covid-19 with no or mild symptoms on admission
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379599/
https://www.ncbi.nlm.nih.gov/pubmed/34419004
http://dx.doi.org/10.1186/s12879-021-06574-x
work_keys_str_mv AT ninomiyatoshifumi riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT otsubokohei riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT hoshinoteppei riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT shimokawamototsugu riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT nakazawamegumi riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT satoyoriko riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT mikumohironori riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT kawakamisatoru riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT mizusakishun riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT moriyusuke riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT arimurahidenobu riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT tsuchiyakawanoyuko riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT inouekoji riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT uchidayujiro riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission
AT nakanishiyoichi riskfactorsfordiseaseprogressioninjapanesepatientswithcovid19withnoormildsymptomsonadmission